Abstract

Polygenic risk scores (PRS) from genome-wide association studies (GWAS) are increasingly used to predict disease risks. However some included variants could be false positives and the raw estimates of effect sizes from them may be subject to selection bias. In addition, the standard PRS approach requires testing over a range of p-value thresholds, which are often chosen arbitrarily. The prediction error estimated from the optimized threshold may also be subject to an optimistic bias. To improve genomic risk prediction, we proposed new empirical Bayes approaches to recover the underlying effect sizes and used them as weights to construct PRS. We applied the new PRS to twelve cardio-metabolic traits in the Northern Finland Birth Cohort and demonstrated improvements in predictive power (in R2) when compared to standard PRS at the best p-value threshold. Importantly, for eleven out of the twelve traits studied, the predictive performance from the entire set of genome-wide markers outperformed the best R2 from standard PRS at optimal p-value thresholds. Our proposed methodology essentially enables an automatic PRS weighting scheme without the need of choosing tuning parameters. The new method also performed satisfactorily in simulations. It is computationally simple and does not require assumptions on the effect size distributions.

Highlights

  • Polygenic risk scores (PRS) from genome-wide association studies (GWAS) are increasingly used to predict disease risks

  • As individual-level genomic data is often not available to researchers due to privacy concerns, we focus on ways to improve risk prediction using GWAS summary statistics, which are freely accessible for a wide range of traits

  • In this study we proposed empirical Bayes approaches to estimating the underlying effect sizes of genetic variants, and made use of these estimates for new ways of constructing PRS

Read more

Summary

Introduction

Polygenic risk scores (PRS) from genome-wide association studies (GWAS) are increasingly used to predict disease risks. To improve genomic risk prediction, we proposed new empirical Bayes approaches to recover the underlying effect sizes and used them as weights to construct PRS. For eleven out of the twelve traits studied, the predictive performance from the entire set of genome-wide markers outperformed the best R2 from standard PRS at optimal p-value thresholds. Besides revealing the underlying pathophysiology of complex diseases, susceptibility variants may be useful in improving the prediction of disease risks or trait values. As individual-level genomic data is often not available to researchers due to privacy concerns, we focus on ways to improve risk prediction using GWAS summary statistics, which are freely accessible for a wide range of traits. The PRS approach has become popular in recent years and has been widely applied to different traits[6,7,8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call